Industry-Supported Symposia

Women are irreplaceable key figures in both society and in families; as such, we must ensure that all aspects of women’s health, including breast cancer care, are looked after. Join our multidisciplinary panel of experts for an engaging discussion on breast cancer awareness, the importance of an early diagnosis, and how the advent of targeted treatments has revolutionised the treatment landscape for HER2-positive breast cancer. Our panel will also discuss key actions we can take to help ensure that all women, worldwide, receive the best possible breast cancer care. These discussions will be followed by a live Q&A, where you will have the opportunity to ask questions to our speakers.

Agenda

• Welcome and introduction: The importance of breast cancer care in women’s health
  Prof. Christian Jackisch, Gynaecological Oncologist, Sana Klinikum Offenbach, Germany
• Why is it vital to diagnose breast cancer early?
  Prof. Nadia Harbeck, Gynaecological Oncologist, LMU Breast Center, Germany
  Prof. Qiang Liu, Surgeon, Sun Yat-Sen Memorial Hospital, China
• The treatment landscape in HER2-positive breast cancer
  Prof. Nadia Harbeck
  Prof. Philippe Descamps, Gynaecologist, CHU Angers University Hospital Center, France
• What can we do differently tomorrow to improve breast cancer care and women’s health?
  Prof. Christian Jackisch
• Live Q&A
  All

For more information, click here.

During pregnancy, an adequate maternal dietary intake is essential to meet the increased nutritional demands required to maintain metabolism and support fetal development. However, women in both developing and industrialized countries are at risk of insufficient nutrient intake that can lead to adverse effects on pregnancy outcomes and neonatal health. After birth, breastfeeding is recommended as the optimal way of infant feeding to support healthy growth and development of the child.  However, the composition of breastmilk can vary depending on the metabolic and nutritional state of the mother, the stage of lactation, and even the time of day (diurnal fluctuations). In this session we will discuss the latest evidence on the role micronutrients play in pregnancy and breastfeeding and how healthcare professionals can support parents for optimal nutrition.

Speakers

• Jennifer Kaczmarek (Chair) | Head of Strategic Messaging, Global Consumer Health Communications, USA
• Berthold Koletzko | Else Köner-Seniorprofessor of Paediatrics, Professor h.c., Dr. med., Dr. med. habil. (MD PhD), Dr. h.c. mult. | Germany
• Irene Cetin | Full Professor of Obstetrics and Gynecology, University of Milan, Head of Department of Woman, Mother and Neonate, Hospital V. Buzzi | Italy
• Dr. Svetlana Dubrovina | Professor, MD, PhD, Chief Scientific Officer of obstetric-gynecological department FSBEI “Rostov State Medical University” of Ministry of Health of Russia, Professor of the Department of Obstetrics and Gynecology №1

For more information, click here.

• Chair
  Johannes Bitzer, MD, Prof Em – Switzerland
• Preventing Unintended pregnancy during COVID
  Amanda Black, MD, MPH, FRSCS – Canada
• Ensuring Effective Options for Reproductive Choices
  Carolina Sales MD, PhD – Brazil
• Counselling young women about the bleeding patterns associated with progestogen-only contraception
  Diana Mansour, FRCOG, FFSRH, DIPM – United Kingdom

This standalone educational symposium is funded and organised by Organon for healthcare professionals only. GB-NON-110218 Organon© Promotional meeting October 2021. Click here for our UK product PI and AE Reporting.

How can you make the difference in maternal immunization? Join GSK in an interactive scientific symposium led by international experts, to discover what drives vaccine acceptance in pregnancy, listen to practical examples of how you can create a culture of maternal immunization and learn how the vaccination of pregnant women is evolving.

Agenda

• Welcome and introduction: where are we now with maternal immunization? (10 minutes)
  Michelle Giles (Chair)
• Which factors influence vaccine acceptance in pregnancy? (10 minutes)
  Emilie Karafillakis
• Protect mother and infant by creating a culture of maternal immunization in your practice (10 minutes)
  Frank Louwen
• The future of maternal immunization (10 minutes)
  Flor Munoz
• Q&A and Concluding remarks (20 minutes)
  All (Q&A), Prof. Michelle Giles (Concluding remarks)

For more information, click here.

• Welcome and introduction (5 minutes)
  Stephan Jacob, Germany (Chair)
• Obesity and PCOS – two complex metabolic diseases (10 minutes)
  Stephan Jacob, Germany (Chair)
• Effective and supportive conversations on weight management (15 minutes)
  Veronica Vazquez Velazquez, Mexico
• How can we support long-term weight control in PCOS (15 minutes)
  Karen Elkind-Hirsch, USA
• Audience Q&A / panel discussion (15 minutes)
  All faculty

For more information, click here.

This session will highlight the role of heat-stable carbetocin for prevention of post-partum haemorrhage (PPH) in the continuum of care as an additional option in low- and lower-middle-income countries, offering predictable quality and effectiveness. The attendees of this session will learn about the challenges and opportunities for translating scientific evidence and guidelines into practice and better outcomes, especially in resource constrained settings, such as sub-Saharan Africa and South East Asia where there is the greatest unmet need. Delegates will also discover Ferring’s ‘Project Family: Safe Birth’ commitment, including its priorities over the coming years to ensure the accessibility of heat-stable carbetocin for prevention of PPH, and collaborative approaches to support capacity building on the ground.

Agenda

• Chairs Introduction – Setting the scene (10 minutes)
  Marleen Temmerman (Kenya)
• Keynote lecture (15 minutes)
  Dilys Walker (USA)
• Panel discussion moderated by Prof. Marleen Temmerman – From scientific evidence to implementation (20 minutes)
  Dilys Walker, Prof. Hadiza Galadanci (Nigeria), Prof. Yeshita V. Pujar (India), Dr. Vishal Shah (Ferring), Dr. Lisa Thomas (Ferring)
• Q&A with the audience moderated by Prof. Marleen Temmerman (10 minutes)
  All faculty
• Close of session (5 minutes)
  Marleen Temmerman

For more information, click here.

Good health and nutrition before conception are key to a mother’s ability to meet the nutrient demands of pregnancy and breastfeeding and are vital to the healthy development of her embryo, fetus, infant, and child. Join Professor Gian Carlo di Renzo and other leading international experts, to hear the latest research in maternal nutritional science and pregnancy outcomes. Topics will include the impact of maternal nutrition on pregnancy outcomes; the continuing occurrence of NTDs despite the recommendation to supplement with folic acid already in pre-conception; L-5-MTHF, a synthetic folate form that showed a higher effi­cacy in increasing folate status compared to folic acid, and new evidence of choline role in fetal development and prevention of NTDs. 

Agenda 

• Welcome & Introductions 
  Professor Gian Carlo di Renzo, Director, Reproductive and Perinatal Medicine Center, University of Perugia, Italy (Chair) 
• How maternal nutrition can impact the pregnancy outcome (10 minutes) 
  Professor Gian Carlo di Renzo 
• What should we know of folate and pregnancy; why NTD remains a problem? (20 minutes) 
  Professor Eduardo Fonseca, Department of Obstetrics and Gynecology, Faculty of Medicine, University of São Paulo (FMUSP), Brazil
• New evidence on choline role in fetal development and prevention of neural tube defects (20 minutes) 
  Professor Rima Obeid, Department of Clinical Chemistry and Laboratory Medicine, Saarland University Hospital, Germany
• Why should gynecologists go beyond folic acid when it comes to maternal nutrition – Conclusion and questions (10 minutes) 
  All faculty, Professor Gian Carlo di Renzo 

During this symposium, the expert faculty will highlight the importance of vaccination to protect the mother from infections that are potentially severe for herself and her newborn child.  Since the hesitancy of healthcare providers to recommend vaccination remains a huge barrier to vaccination in pregnancy, strategies shown to improve vaccination rates among pregnant women will be discussed. These include improving patient awareness, staff education and training, and health system improvements.

• Mission: Objective (10 minutes) | Prof Shabir Madhi
  • Protection of pregnant women and young infants through vaccination during pregnancy
  • Burden of vaccine-preventable diseases and rationale for vaccination in pregnancy
• Mission: Exploration (10 minutes) | Dr Eliana Castillo
  • Considerable data demonstrate that vaccination in pregnancy is both safe and effective
  • Overview of clinical data supporting safe and effective vaccination in pregnant women
• Mission: Challenges (10 minutes) | Dr Katherine Chen
  • The challenges around vaccination in pregnancy
  • Barriers to vaccination and reasons for vaccine hesitancy in pregnant women
• Mission: Specialists (10 minutes) | Dr Rodrigo Orozco Fernandez
  • Role of OB/GYNs in overcoming barriers to vaccination in pregnancy – actual implementation solutions
  • Importance of healthcare provider recommendations for building confidence
• Mission: Debrief (20 minutes) | All faculty led by Dr Katherine Chen
  • Panel discussion: Q&A with faculty

For more information, click here.

• Quantitative Fetal Fibronectin Testing for Women with Signs and Symptoms of Preterm Labour – Sharing Latest Data and Best Practice from the UK
  Chaired by Professor Bo Jacobsson, MD, PhD
• Why Quantify Fetal Fibronectin when Identifying Women in Preterm Labour? | Introducing the concept of quantitative fFN testing and the value it adds in a clinical setting
  Professor Andrew Shennan, Professor of Obstetrics, King’s College London, St. Thomas’ Hospital; Clinical Director, South London Clinical Research Network
• Update on the QUIDS Study (Parts 1 & 2) – Quantitative Fetal Fibronectin in Clinical Practice
  Following the recent publication of the QUIDS study, Dr Sarah Stock will share some key insights from the data. A prospective cohort study from 26 UK Centres, the aim of the QUIDS study was to develop and validate a risk prediction model of preterm birth for women with preterm labour symptoms. Mrs Jessica Thompson, working alongside Dr Stock, will share the practical elements of rolling out such a service in clinical practice.
  Dr Sarah Stock, honorary Consultant and Subspecialist in Maternal and Fetal Medicine, MRC Centre for Reproductive Health, University of Edinburgh, Scotland
  Mrs Jessica Thompson, Research Midwife, Edinburgh Royal Infirmary, Scotland

For more information, click here.

The first 1,000 days of life concept highlights the importance of adequate nutrition between conception (day 1) and a child’s second birthday (day 1000) as the most critical period of growth and development. However, this unique window of development has far-reaching impacts on the child´s ability to thrive through adulthood and can be heavily influenced before conception. Join us as we discuss with experts how male and female nutrition in pre-conception and pregnancy leads to a healthy first 1000 days and how you can support the next generation of parents-to-be through education on lifestyle and nutritional choices. 

Speakers 

• Jennifer Kaczmarek (Chair) | Head of Strategic Messaging, Global Consumer Health Communications, USA 
• Dr. Irene Cetin | Full Professor of Obstetrics and Gynecology, University of Milan, Head of Department of Woman, Mother and Neonate, Hospital V. Buzzi | Italy 
• Dr. Jackson Kirkman-Brown | Andrologist, HFEA Person Responsible, Birmingham Women’s Fertility Centre, University Birmingham, UK 

For more information, click here.

Women are irreplaceable key figures in both society and in families; as such, we must ensure that all aspects of women’s health, including breast cancer care, are looked after. Join our multidisciplinary panel of experts for an engaging discussion on breast cancer awareness, the importance of an early diagnosis, and how the advent of targeted treatments has revolutionised the treatment landscape for HER2-positive breast cancer. Our panel will also discuss key actions we can take to help ensure that all women, worldwide, receive the best possible breast cancer care. These discussions will be followed by a live Q&A, where you will have the opportunity to ask questions to our speakers.

Agenda

• Welcome and introduction: The importance of breast cancer care in women’s health
  Prof. Christian Jackisch, Gynaecological Oncologist, Sana Klinikum Offenbach, Germany
• Why is it vital to diagnose breast cancer early?
  Prof. Nadia Harbeck, Gynaecological Oncologist, LMU Breast Center, Germany
  Prof. Qiang Liu, Surgeon, Sun Yat-Sen Memorial Hospital, China
• The treatment landscape in HER2-positive breast cancer
  Prof. Nadia Harbeck
  Prof. Philippe Descamps, Gynaecologist, CHU Angers University Hospital Center, France
• What can we do differently tomorrow to improve breast cancer care and women’s health?
  Prof. Christian Jackisch
• Live Q&A
  All

For more information, click here.

There is huge potential for real world data (RWD) to improve women’s health. Health care practitioners should consider exploring RWD that’s generated by a relatively new industry — femtech — because it provides unique opportunities in research, better quality of care, and patient education.

Read more about the symposium here.

Speakers

• Lubna Pal, Flo Medical Board Member, Professor of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine
• Anna Klepchukova, Chief Medical Officer at Flo Health
• Andrei Varanovich, Head of Data Science at Flo Health

During the session, the expert panel will explore the impact of ICP, examine recent advances and current challenges in its management, as well as looking at emerging therapies for ICP and reviewing case studies. The speakers will expand on some of these themes further during a panel discussion.

If you would like to ask the symposium speakers any questions, please submit them via the following link: https://www.surveymonkey.co.uk/r/Q6LX69D

Speakers

• Catherine Williamson, MD, FRCP, Department of Women and Children’s Health, King’s College London, London, UK
• Christian Pettker, MD, Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States
• Caroline Ovadia, MD, PhD, Department of Women and Children’s Health, King’s College London, London, UK

Women are irreplaceable key figures in both society and in families; as such, we must ensure that all aspects of women’s health, including breast cancer care, are looked after. Join our multidisciplinary panel of experts for an engaging discussion on breast cancer awareness, the importance of an early diagnosis, and how the advent of targeted treatments has revolutionised the treatment landscape for HER2-positive breast cancer. Our panel will also discuss key actions we can take to help ensure that all women, worldwide, receive the best possible breast cancer care. These discussions will be followed by a live Q&A, where you will have the opportunity to ask questions to our speakers.

Agenda

• Welcome and introduction: The importance of breast cancer care in women’s health
  Prof. Christian Jackisch, Gynaecological Oncologist, Sana Klinikum Offenbach, Germany
• Why is it vital to diagnose breast cancer early?
  Prof. Nadia Harbeck, Gynaecological Oncologist, LMU Breast Center, Germany
  Prof. Qiang Liu, Surgeon, Sun Yat-Sen Memorial Hospital, China
• The treatment landscape in HER2-positive breast cancer
  Prof. Nadia Harbeck
  Prof. Philippe Descamps, Gynaecologist, CHU Angers University Hospital Center, France
• What can we do differently tomorrow to improve breast cancer care and women’s health?
  Prof. Christian Jackisch
• Q&A
  All

For more information, click here.